Subsequent reductions in insurance prices irritate the domestic pharmaceutical industry

Published: 2002-06-28 06:59:00

Updated: 2002-06-28 06:59:00

Pharmaceutical industry observers say that many domestic pharmaceutical firms, which have been heavily dependent on the exclusive wholesaling business due to their fragile distribution structure in the regional areas, will be subject to subsequent reductions in medical insurance prices, unless th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK